|
2-[(2E)-2-[(3-ethoxy-2-hydroxyphenyl)methylidene]hydrazinyl]-2-sulfanylidene-N-[2-(trifluoromethyl)phenyl]acetamide |
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
2-[(2E)-2-[(3-ethoxy-2-hydroxyphenyl)methylidene]hydrazinyl]-N-(4-fluorophenyl)-2-sulfanylideneacetamide |
Depiction based on curated SMILES
F
HN
O
CH
3
S
HN
N
HO
O
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
2-[(2Z)-2-[(3-ethoxy-2-hydroxyphenyl)methylidene]hydrazinyl]-2-sulfanylidene-N-[3-(trifluoromethyl)phenyl]acetamide |
Depiction based on curated SMILES
NH
F
F
F
CH
3
O
S
NH
N
OH
O
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
4-[(3-ethoxy-2-hydroxyphenyl)methyl]-N-(4-fluorophenyl)-5-oxo-1,3,4-thiadiazine-2-carboxamide |
Depiction based on curated SMILES
O
S
F
H
3
C
NH
O
N
N
OH
O
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Zigangirova NA, et al. 2012. Acta Naturae |
|
5-nitro-7-[(3-phenylpyrrolidin-1-yl)methyl]quinolin-8-ol |
Depiction based on curated SMILES
N
OH
O
N
_
O
+
N
|
Chlamydia Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Enquist PA, et al. 2012. Bioorg Med Chem Lett
|
|
5-nitro-7-[(4-phenyl-1-piperazinyl)methyl]-8-quinolinol |
Depiction based on curated SMILES
N
OH
O
N
N
_
O
+
N
|
Chlamydia Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Enquist PA, et al. 2012. Bioorg Med Chem Lett
|
|
7-[[4-(4-fluorophenyl)piperazin-1-yl]methyl]-5-nitroquinolin-8-ol |
Depiction based on curated SMILES
N
OH
F
O
N
N
_
O
+
N
|
Chlamydia Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Enquist PA, et al. 2012. Bioorg Med Chem Lett
|
|
N'-(2-Hydroxy-3,5-dibromobenzylidene)-4-nitrobenzhydrazide |
Depiction based on curated SMILES
Br
_
O
O
+
N
OH
O
Br
N
HN
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Wolf K, et al. 2006. Mol Microbiol |
|
N-[(E)-(3-fluoro-2-hydroxyphenyl)methylideneamino]-4-nitrobenzamide |
Depiction based on curated SMILES
_
O
O
+
N
OH
O
F
N
N
H
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Dahlgren MK, et al. 2010. Bioorg Med Chem |
|
N'-[(E)-(5-bromo-2-hydroxyphenyl)methylidene]-2-phenylacetohydrazide |
Depiction based on curated SMILES
N
OH
Br
O
N
H
|
Chlamydia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Dahlgren MK, et al. 2010. Bioorg Med Chem |
|
| | |